5,10-dihydrodipyrido[2,3-b:2,3-e]pyrazin and 5,10-dihydrodipyrido[2,3-b:3,2-e]pyrazin compounds
US6127369A · kind A · utility
0Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 11, 1999 |
| Grant date | Oct 3, 2000 |
| Priority date | — |
| Expiry date | Jun 11, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound selected from those of formula (I): ##STR1## wherein: X represents N, C or CH, PA0 Y represents N when X represents C or CH, or Y represents C or CH when X represents N, PA0 R.sub.1 represents an optionally substituted alkyl, PA0 R.sub.2 and R.sub.3, which may be identical or different, represent Z or W, as defined in the description, their isomers and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same which are useful in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.